SAN FRANCISCO — Nearly half of patients with noninfectious uveitis treated with suprachoroidal CLS-TA gained three or more lines of visual acuity after 24 weeks, according to a presentation at the American Academy of Ophthalmology annual meeting.
Steven Yeh, MD, M. Louise Simpson Associate Professor of Ophthalmology at Emory Eye Center, and colleagues conducted the PEACHTREE study – a phase 3, randomized, controlled, double masked, multicenter trial – to assess the effect of suprachoroidal CLS-TA (triamcinolone acetonide injectable suspension) on IOP among patients with
Uncategorized